ISIIH 12th

Title Content type
In vitro susceptibility of clinical isolates of Aspergillusfimigatus to conventional and lipid formulations of amphotericin B in 2-drug combination with caspofimgin and micafungin (click for details)
Opportunistic infections of the respiratory system in adults patients with HIV/AIDS (click for details)
Antifungal activity of voriconazole alone and in twodrug combination with amphotericin B in a guinea pig pulmonary aspergillosis model (click for details)
Comparison of Aspergillus nidulans and Aspergillus fumigatus as causes of osteomyelitis in patients with chronic granulomatous disease (click for details)
Infectious morbidity after non myeloablative allogeneic bematopoietic stem cell transplantation (AHSCT) (click for details)
Antifungal efficacy, pharmacokinetics and pharmacodynamics of intravenous itraconazole against invasive pulmonary aspergillosis in persistently neutropenic rabbits (click for details)
Infections in hematopietic stem cell transplant (HSCT) recipients (RC): 1994-2001 (click for details)
New paradigms for the treatment of aspergillosis: polyenes (click for details)
Interleukin-15 (IL-15) enhances the release of interleukin-8 (IL-Q, but not of tumor necrosis factoralpha (TNF-alpha) from unstimulated polymorphonuclear leukocytes and following challenge by Aspergillus species (click for details)
Multicenter randomized trial of intra venous/oral itraconazole vs. intra venous/oral fluconazole for long-term antifungal prophylaxis in allogeneic bone marrow transplant patients (click for details)

Pages

Subscribe to ISIIH 12th